This could have an impact in the vector efficacy, as a balanced immune response targeting epitopes present in Env, Gag, Pol or Nef after vaccination will likely result in more effective inhibition of HIV-1 infection. This evidence concerns the gene ERVW-1 and HIV-1 infection.